At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
DERMABOND +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Randomized Trial of Dermabond Prineo Wound Closure System on Operating Room Time and Wound Closure Time in Total Knee Arthroplasty
In Brief
A clinical study evaluating DERMABOND and Staples for Wound Heal. Completed, enrolled 60 participants across 1 site.
Detailed Summary
In this prospective pilot study examining the superficial closure during total knee arthroplasty, active subjects will receive the STRATAFIX Spiral Knotless Tissue Control Device for subcuticular closure in addition to DERMABOND PRINEO (Ethicon, Johnson and Johnson, Somerville, New Jersey) system for dermal closure. The control subjects will receive staples (standard-of-care).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWound Heal
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartSep 2017
First PostedSep 2017
Primary CompletionMar 2019
Study CompletionJun 2019
TodayJul 2026
First PostedSep 18, 2017
Enrollment StartSep 15, 2017
Primary CompletionMar 25, 2019
Study CompletionJun 30, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.8 years ago
Interventions
DERMABONDdevice
DERMABOND PRINEO (Ethicon, Johnson and Johnson, Somerville, New Jersey)
Staplesdevice
staples for skin closure